4
Changes in Ownership
Candel Therapeutics, Inc. Filed Acc 0000950170-25-093035
Chief Medical Officer sold 781 shares at $5.04 ($3,936)
- Chief Medical Officer acquired 781 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Nichols William Garrett · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-06-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +781 | $1.29 | $1,007 | 53,274 | D |
| 2025-06-30 | Sale : show line 2 in the form 10b5-1 | −781 | $5.04 | $3,936 | 52,493 | D |
| Open-market sales · 781 sh · avg $5.04 · $3,936 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-06-30 | Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) | −781 | 30,314 | D |
Loading xslF345X05/ownership.xml…